Paulette Bioulac-Sage Selected Research

Glypicans

1/2020	miR-4510 blocks hepatocellular carcinoma development through RAF1 targeting and RAS/RAF/MEK/ERK signalling inactivation.
1/2013	A functional screening identifies five microRNAs controlling glypican-3: role of miR-1271 down-regulation in hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paulette Bioulac-Sage Research Topics

Disease

59	Neoplasms (Cancer) 01/2021 - 04/2003
42	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 05/2002
41	Liver Cell Adenoma (Hepatocellular Adenoma) 03/2024 - 11/2003
14	Fibrosis (Cirrhosis) 10/2018 - 05/2002
13	Adenoma (Adenomas) 01/2020 - 04/2003
12	Focal Nodular Hyperplasia 01/2019 - 03/2003
11	Carcinogenesis 01/2017 - 03/2005
9	Hemorrhage 02/2024 - 08/2009
7	Carcinoma (Carcinomatosis) 01/2020 - 05/2005
5	Liver Neoplasms (Liver Cancer) 08/2017 - 04/2007
5	Inflammation (Inflammations) 05/2013 - 01/2006
3	Hepatoblastoma 05/2023 - 12/2008
3	Liver Diseases (Liver Disease) 01/2019 - 12/2006
3	Necrosis 01/2018 - 01/2008
3	Cholestasis 12/2017 - 05/2002
3	Glycogen Storage Disease (Glycogenosis) 04/2014 - 01/2008
3	Cholangiocarcinoma 03/2011 - 04/2007
3	Infections 06/2008 - 01/2002
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 03/2024 - 01/2013
2	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2019 - 01/2019
2	Hepatitis C 01/2019 - 09/2005
2	Hypersensitivity (Allergy) 01/2019 - 02/2010
2	Type 3 Maturity-Onset Diabetes of the Young 01/2013 - 11/2003
2	Obesity 09/2012 - 01/2008
2	Rectal Neoplasms (Rectal Cancer) 01/2008 - 05/2005
2	Chronic Hepatitis C 12/2006 - 06/2003
1	Non-alcoholic Fatty Liver Disease 01/2019

Drug/Important Bio-Agent (IBA)

25	CateninsIBA 03/2024 - 12/2010
18	beta CateninIBA 01/2021 - 08/2004
13	Proteins (Proteins, Gene)FDA Link 05/2023 - 09/2005
13	Oral ContraceptivesIBA 01/2019 - 03/2003
8	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 03/2024 - 03/2009
6	Messenger RNA (mRNA)IBA 01/2020 - 04/2007
6	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2020 - 03/2005
6	Interleukin-6 (Interleukin 6)IBA 01/2016 - 01/2009
6	Hepatocyte Nuclear Factor 1-alpha (Hepatocyte Nuclear Factor 1 alpha)IBA 02/2010 - 11/2003
5	Hepatocyte Nuclear FactorsIBA 01/2020 - 03/2007
5	C-Reactive ProteinIBA 10/2019 - 01/2010
4	Glutamine (L-Glutamine)FDA Link 02/2024 - 02/2008
4	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 12/2012
4	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 06/2004
4	Transcription Factors (Transcription Factor)IBA 02/2010 - 11/2004
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2013
3	Fatty Acid-Binding ProteinsIBA 01/2020 - 03/2009
3	RNA (Ribonucleic Acid)IBA 01/2019 - 11/2009
3	ParaffinIBA 12/2017 - 04/2017
3	MicroRNAs (MicroRNA)IBA 01/2017 - 06/2008
3	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2016 - 03/2009
3	Hormones (Hormone)IBA 04/2014 - 01/2008
3	Protein Isoforms (Isoforms)IBA 01/2014 - 05/2007
3	Adenosine Triphosphatases (ATPase)IBA 12/2012 - 10/2007
2	ApolipoproteinsIBA 01/2020 - 09/2005
2	GlypicansIBA 01/2020 - 01/2013
2	Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA 10/2019 - 12/2017
2	gadolinium ethoxybenzyl DTPA FDA Link 01/2019 - 07/2013
2	Cyclin A2IBA 12/2018 - 10/2015
2	CyclinsIBA 12/2018 - 10/2015
2	Epithelial Cell Adhesion MoleculeIBA 10/2018 - 12/2013
2	Formaldehyde (Formol)FDA Link 12/2017 - 12/2017
2	Aflatoxin B1 (Aflatoxin B)IBA 11/2017 - 05/2015
2	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 04/2017 - 03/2007
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2016 - 06/2008
2	Fatty Acids (Saturated Fatty Acids)IBA 02/2013 - 05/2007
2	Colloids (Colloid)IBA 01/2013 - 05/2005
2	Small Interfering RNA (siRNA)IBA 10/2011 - 10/2007
2	IronIBA 04/2010 - 05/2005
2	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2008 - 01/2007
2	Thrombin FDA Link 01/2008 - 01/2006
2	Fibrillin-1IBA 01/2004 - 05/2002
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	regorafenibIBA 01/2020
1	Immunologic Factors (Immunomodulators)IBA 01/2020
1	AlbuminsIBA 01/2020
1	Apolipoproteins B (ApoB)IBA 01/2020
1	cabozantinibIBA 01/2019
1	Oxidoreductases (Dehydrogenase)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	micaIBA 01/2019
1	pgRNAIBA 01/2018
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2018
1	sodium-bile acid cotransporterIBA 01/2018
1	Reticulin (Reticular Fiber)IBA 12/2017
1	Hematoxylin (Haematoxylon)IBA 12/2017
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2017
1	Coloring Agents (Dyes)IBA 12/2017
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2017
1	Vinblastine (Vinblastine Sulfate)FDA Link 08/2017
1	JNJ38877605IBA 08/2017
1	5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- oneIBA 08/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2017

Therapy/Procedure

6	Therapeutics 01/2020 - 09/2004
5	Liver Transplantation 01/2018 - 01/2002
3	Hepatectomy 04/2017 - 11/2005
3	Drug Therapy (Chemotherapy) 01/2014 - 05/2005
3	Contraception (Birth Control) 02/2013 - 03/2007
3	Radiotherapy 01/2008 - 05/2005
2	Radiofrequency Ablation 12/2013 - 11/2006
2	Chemoradiotherapy 04/2010 - 01/2008
1	Critical Care (Surgical Intensive Care) 11/2021
1	Lasers (Laser) 12/2017